HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
RNA therapeutics represents a cutting-edge avenue in the field of cancer treatment, leveraging the potential of RNA molecules to target and modulate the expression of genes associated with cancer. This innovative approach encompasses various RNA-based strategies, including RNA interference (RNAi), small interfering RNA (siRNA), messenger RNA (mRNA), and antisense oligonucleotides. RNA therapeutics holds promise in addressing some of the challenges posed by traditional cancer treatments, offering a more targeted and precise method of intervention.
One prominent application is RNA interference, where small RNA molecules are used to silence or inhibit the expression of specific genes involved in cancer progression. This targeted gene silencing can disrupt key pathways in cancer cells, potentially leading to their demise. Additionally, mRNA-based therapies have emerged as a novel strategy for cancer vaccines, utilizing the body's own cellular machinery to produce therapeutic proteins that stimulate an immune response against cancer cells. As research in RNA therapeutics continues to advance, it opens new avenues for developing highly specific and customizable treatments, bringing us closer to the era of personalized cancer therapy.
